{
  "drug_name": "TC-2696",
  "generic_name": [
    "TECHNESCAN TC 99M MERTIATIDE"
  ],
  "brand_names": [
    "Technescan MAG3"
  ],
  "drug_interactions": [],
  "warnings": [
    "WARNINGS None known."
  ],
  "adverse_reactions": [
    "ADVERSE REACTIONS The following adverse reactions have been reported: nausea, vomiting, wheezing, dyspnea, itching, rash, tachycardia, hypertension, shaking chills, fever, and seizure."
  ],
  "contraindications": [
    "CONTRAINDICATIONS None known."
  ],
  "dosage_administration": [
    "DOSAGE AND ADMINISTRATION The suggested dose range employed in the average adult patient (70 kg) for renal function and imaging studies is 185 MBq (5 mCi) to 370 MBq (10 mCi). In pediatric patients the recommended dose range is 2.6 MBq/kg (70 \u03bcCi/kg) to 5.2 MBq/kg (140 \u03bcCi/kg) with a minimum dose of 37 MBq (1 mCi). The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Aseptic procedures and a shielded syringe should be employed in withdrawing doses for administration to patients. The user should wear waterproof gloves during the administration procedure."
  ],
  "indications": [
    "INDICATIONS AND USAGE Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use. ) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex."
  ],
  "fetched_at": "2025-10-01T16:01:40.758030",
  "source": "OpenFDA"
}